Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This study was designed to investigate treatment of postoperative pulmonary hypertension by
iloprost inhalation in children with congenital heart defects. It was a controlled
single-blind randomized multi-center prospective study in order to explore the efficacy of
this method in the treatment and prevention of pediatric pulmonary hypertension after
corrective open-heart surgery for congenital heart defects.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborator:
Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery